5728-55-2

Basic information

• Product Name: 1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide
• CAS NO: 5728-55-2
• Molecular Formula: C₁₄H₁₁BrO₂
• Molecular Weight: 510.572
• Mol File: 5728-55-2.mol
• Article Data: 2

Chemical Properties

• Density: 1.63g/cm³
• Refractive Index: 1.805
• CAS DataBase Reference: 1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide(5728-55-2)
• EPA Substance Registry System: 1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide(5728-55-2)

Safety Data

• Hazardous Substances Data: 5728-55-2(Hazardous Substances Data)

Usage

General Description

1-(3-methyl-2,6-dioxo-7-{3-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]propyl}-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide is a complex organic compound composed of a purine ring, a piperidine ring, and a tetrazole ring. It also contains a sulfanyl group and a carboxamide group. The compound is a synthetic molecule that may have potential applications in pharmaceutical research and drug development due to its unique structure and potential biological activities. Its precise properties and potential uses would need to be further studied and characterized in a laboratory setting.

Upstream product

• 5731-01-1 4-bromo-4'-acetylbiphenyl 
• 92-66-0 4-bromo-1,1'-biphenyl 
• 5728-51-8 4-[(4'-bromo-biphenyl-4-yl)-thioacetyl]-morpholine 

Downstream Products

• 1402466-02-7 ethyl 2-(4'-(5-amino-1-methyl-1H-pyrazol-4-yl)biphenyl-4-yl)acetate 
• 1402466-03-8 ethyl 2-(4'-(5-((1-(2-chlorophenyl)ethoxy)carbonylamino)-1-methyl-1H-pyrazol-4-yl)biphenyl-4-yl)acetate 
• 1402465-12-6 2-(4'-(5-((1-(2-chlorophenyl)ethoxy)carbonylamino)-1-methyl-1H-pyrazol-4-yl)biphenyl-4-yl)acetic acid 
• 1396007-84-3 [4'-(4,4,5,5-tetramethyl-[1,3,2]di-oxaborolan-2-yl)-biphenyl-4-yl]-acetic acid ethyl ester 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR MODULATING LPA RECEPTORS

The present invention relates to compounds of Formula (1), or pharmaceutically acceptable salts thereof and their pharmaceutical compositions, wherein variables are as defined herein, which are useful as modulators of the activity of lysophosphatidic acid (LPA).